2-Chloro-6-fluoro-3-methoxybenzyl bromide, 97%, 10g

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 97.0%, 25g

2-Amino-6-azaspiro[3.4]octan-5-one hydrochloride, 98%, 500mg

(S)-(-)-2-Aminomethyl-1-ethylpyrrolidine>98.0%(GC)(T)5g

Cyclohexylamino-acetic acid ethyl ester, 95.0%, 5g

4-methyl-2-(1-methylpiperidin-4-yl)thiazole-5-carboxylic acid dihydrochloride, 95.0%, 500mg

2.32M HCL in Methanol (HCl 10% w/w), 750g

TERT-BUTYL (2,2-DIFLUORO-3-HYDROXYPROPYL)CARBAMATE, 95.0%, 1g

3-(thiophen-2-yl)isoxazol-5-amine, 95.0%, 250mg

1-Phenyl-1-butyne>97.0%(GC)5mL

Récipient de réaction à bride plate cylindrique, gradué (1) Fond rond, DN 200, 215 mm, Hauteur, 310 mm, 1 Pièce

(R)-Morpholine-3,4-dicarboxylic acid 4-tert-butylester, 95.0%, 25g

{1-[3-(2-methylphenyl)-1,2,4-oxadiazol-5-yl]ethyl}amine hydrochloride, 95.0%, 1g